Munich · On-site
Cellbyte
Backed byFrontline VenturesAbout Cellbyte
Cellbyte is building an AI-native platform to help pharma companies launch new drugs worldwide. The company empowers pharma commercial teams to cut through complexity, analyze previously fragmented data in seconds, and automate high-stakes workflows. It builds AI agents for pharmaceutical drug launches and automates repetitive workflows on a robust data foundation, helping bring life-changing treatments to patients faster. Backed by Y-Combinator, Cellbyte positions itself as an AI-native platform for pharma drug launches.
Open positions · 3
Munich · On-site
Munich · On-site
Company at a glance
Location
About the Team
Team Distribution
- Leadership40%
- Engineering40%
- Operations20%
Where the Team Studied
- 1.Technical University of Munich
- 2.Ludwig-Maximilians-Universität München
- 3.Freie Universität Berlin
- 4.Durham University
- 5.RWTH Aachen University
Team Worked At
- Kinapse
- Celonis
- BCG
- Siemens
- appliedAI Initiative GmbH
Funding History
$2.8M
raised
AI drug-launch platform Cellbyte raised a $2.75 million seed round led by Frontline Ventures with participation from Y Combinator, Pace Ventures, Saras Capital and Springboard Health Angels.
Life at Cellbyte
Frequently asked questions
Companies similar to Cellbyte
Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.
Founded by Ayla, a former healthcare investor and EMT, and August, a founding engineer with deep expertise in voice and AI healthcare, this San Francisco-based company is transforming emergency medical services billing and claims. Backed by Eniac and Euclid Ventures at the pre-seed stage, the company is already live with customers and approaching $1M in annual recurring revenue. The lean, two-person founding team is deliberately building a small, elite organization focused on solving critical pain points in the EMS industry. With founders who combine both operational healthcare experience and technical sophistication, the company is positioned to bring much-needed innovation to a traditionally fragmented and inefficient market.
Aniva is a health optimization company. It positions itself as a preventive health operating system. It markets itself as Europe's most comprehensive blood check-up. Its mission is to simplify the journey to better health, making it accessible and effective for everyone.
